,Q2 2025,Q2 2024
GAAP EPS from continuing operations (GAAP EPS),$ 1.34,$ 2.17
Special items:,,
Net costs for significant litigation,0.79,0.44
(Increase) decrease in value of Solventum ownership,0.01,(2.00)
Pension risk transfer charge,—,1.09
Manufactured PFAS products,0.02,—
Divestiture costs,—,0.23
Adjusted EPS from continuing operations (adjusted EPS),$ 2.16,$ 1.93
Memo:,,
GAAP operating income margin,18.0 %,20.3 %
Adjusted operating income margin,24.5 %,21.6 %
